Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections
Publication Date
3-24-2020
DOI
10.1128/AAC.02291-19
ISSN
0066-4804
Publication Title
Antimicrobial Agents and Chemotherapy
Recommended Citation
Jorgensen, S. C. J., Trinh, T. D., Zasowski, E. J., Lagnf, A. M., Simon, S. P., Bhatia, S., Melvin, S. M., Steed, M. E., Finch, N. A., Morrisette, T., Estrada, S. J., Rosenberg, J. R., Davis, S. L., & Rybak, M. J. (2020). Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrobial Agents and Chemotherapy, 64(4), e02291-19. https://doi.org/10.1128/AAC.02291-19
PubMed ID
31932379
COinS